According to the report released by Sky News on Thursday, 16 July 2020. Oxford vaccine could provide double protection. The vaccine being developed at Oxford, is one of the leading contenders in the global race to protect against coronavirus.
Researchers at the University of Oxford are convinced they have made a huge breakthrough, after many months in the development of a vaccine for COVID-19. Human trials are reported to have shown huge promising results, after their team discovered the vaccine could possibly provides "double protection" against COVID-19.
Here is the screenshot of Sky News report:
In addition, David Carpenter, the Chairman of Berkshire Research Ethics Committee, which approved the Oxford trial has stated that, if everything goes well, the vaccine could be fairly widely available around September.
This encouraging early results from clinical trials have raised hope. The race to create a COVID-19 vaccine is certainly accelerating. Oxford vaccine is designed to stimulate two parts of the immune systems, producing neutralising antibodies and T-cells, both of which can play a key in preventing viral infection.
BBC News also revealed that, early results from two trials in the US, run by the Pharmaceutical Giant Pfixer and Biotech Company Moderna, suggest both their vaccines could produce a good immune response in volunteers.
India Today, also captured the news of the latest development. As the world battles the COVID-19 pandemic, India Today reveals that 35 companies and academic institutions across the world, are racing against time to create vaccine for the virus.
India Times also released a video that shows how Oxford vaccine is in final phase. Here is the link to the Facebook video they uploaded:
Are you wondering, who are the people funding the research? Here is your answer.
Amidst the COVID-19 pandemic, Zuckerberg donated $25 million to a Bill and Melinda Gates Foundation-backed accelerator that is searching for treatments for the disease. He also announced $25 million in grants to support local journalism that was impacted by the pandemic, and $75 million in advertisement purchases in local newspapers by Facebook, Inc.
On 15 April 2020, The Bill & Melinda Gates Foundation announced an expansion of its funding for the global response to COVID-19. The increase includes an additional $150 million of grant funding, plus a commitment to leverage the resources of the foundation’s Strategic Investment Fund, which could be deployed to catalyze the rapid procurement of essential medical supplies and help life sciences companies secure financing to produce COVID-19 products.
In announcing the funding, the foundation called on world leaders to unite in a global response to COVID-19 to ensure equitable access to diagnostics, treatments, and vaccines.
Bill Gates once said and I quote, "One of our first big investments was to an organization called Gavi, the Vaccine Alliance. Since 2000, Gavi and partners have immunized more than 760 million children, saving over 13 million lives. And now, Gavi has a new effort underway to purchase COVID-19 vaccines for lower-income countries as soon as they are available."